Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Embraer S.A. (ERJ - Analyst Report) launched its operation base in Bangladesh, with the official unveiling of two Embraer jets – ERJ 145 by a Bangladesh based airline, NovoAir. This airline provides aviation services for both cargo transportation and leisure travel.
ERJ 145 is a regional jet with a capacity of 50 passengers. The jets will fly only domestic routes, including Dhaka and Chittagong in the first year of operation. Second year onwards the network will be broadened to include certain regional and international routes.
The jet was initially launched by Embraer in the year 1996, as a part of the ERJ 145 Regional Jet family. The motive of the launch was to address the growing demand among regional airlines for medium-range, jet-powered aircraft that offered more speed, comfort and capacity than a turboprop.
Embraer faces a stiff competition from other industry players. Recently, in early December 2012, the company lost an important contract from Delta Airlines for forty 50-seater ERJ 145 jets along with an option of 30 more jets in the future, to one of the rivals, Bombardier Inc. This was seen as a major blow to the company’s future performance, leading to a downward revision of estimates by many firms.
Subsequent to the introduction of ERJ 145 in Bangladesh, the products from Embraer will now be used by 85 airlines in 51 countries around the world.
The stock bears a Zacks Rank #3 (Strong Sell). The company’s major competitors Boeing Co. (BA - Analyst Report), Lockheed Martin Corporation (LMT - Analyst Report) and Northrop Grumman Corporation (NOC - Analyst Report) also have a Zacks Rank #3 (Hold).
Get the full Analyst Report on NOC - FREE
Get the full Analyst Report on ERJ - FREE
Get the full Analyst Report on BA - FREE
Get the full Analyst Report on LMT - FREE